ClearPoint Neuro, Inc. Quarterly report pursuant to sections 13 or 15(d)

Quarterly report pursuant to sections 13 or 15(d)

Note 6 - Related Party Notes Payable (Tables)

Note 6 - Related Party Notes Payable (Tables)

9 Months Ended

Sep. 30, 2012

Assumptions Used in Calculating Fair Value of Derivative Liability [Table Text Block]

		September 30, 2012				December 31, 2011
Dividend yield			0	%			0	%
Expected volatility			42.47	%			46.58	%
Risk free interest rate			0.27	%			0.25	%
Expected remaining term (years)			2.1				0.15
Common stock price		$	2.12			$	0.60

Schedule of Related Party Transactions [Table Text Block]

		September 30, 2012				December 31, 2011

BSC Notes - principal		$	4,338,601			$	3,500,000
Summer 2011 Notes - principal			-				1,310,000
Total related party notes payable - principal			4,338,601				4,810,000
BSC Notes - unamortized discount			-				-
Summer 2011 Notes - unamortized discount			-				(432,706	)
Total related party notes payable - unamortized discount			-				(432,706	)
BSC Notes - net			4,338,601				3,500,000
Summer 2011 Notes - net			-				877,294
Total related party notes payable - net		$	4,338,601			$	4,377,294